CORRECTION article

Front. Nutr., 22 August 2023

Sec. Clinical Nutrition

Volume 10 - 2023 | https://doi.org/10.3389/fnut.2023.1276556

Corrigendum: Probiotics for the treatment of docetaxel-related weight gain of breast cancer patients—A single-center, randomized, double-blind, and placebo-controlled trial

  • 1. Department of Breast Surgery, Tangshan People's Hospital, Tangshan, Hebei, China

  • 2. Department of Breast and Thyroid Surgery, Third Xiangya Hospital, Central South University, Changsha, China

  • 3. Department of Medical Imaging (Ultrasound), Tangshan Central Hospital, Tangshan, China

  • 4. Hunan Province Key Laboratory of Brain Homeostasis, Third Xiangya Hospital, Central South University, Changsha, China

  • 5. Center for Experimental Medicine, Third Xiangya Hospital, Central South University, Changsha, China

  • 6. Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, China

Article metrics

View details

1,3k

Views

598

Downloads

In the published article, there was an error in affiliation [1]. Instead of “Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, China”, it should be “Department of Breast Surgery, Tangshan People's Hospital, Tangshan, Hebei, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

docetaxel-related weight gain, breast cancer, docetaxel-based chemotherapy, gut microbiota, metabolism

Citation

Juan Z, Qing Z, Yongping L, Qian L, Wu W, Wen Y, Tong J and Ding B (2023) Corrigendum: Probiotics for the treatment of docetaxel-related weight gain of breast cancer patients—A single-center, randomized, double-blind, and placebo-controlled trial. Front. Nutr. 10:1276556. doi: 10.3389/fnut.2023.1276556

Received

12 August 2023

Accepted

14 August 2023

Published

22 August 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

10 - 2023

Updates

Copyright

*Correspondence: Boni Ding

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics